The HSE Waiting List Crisis: How Long Are People Actually Waiting, for What, and Where?

The waiting list for an outpatient appointment at an Irish public hospital is, for many patients, the defining experience of the Irish healthcare system. You receive a letter saying your GP has referred you to a specialist. You wait. Months pass. Sometimes more than a year. Sometimes several years. The condition you were referred for may resolve itself, worsen, or in a minority but not negligible number of cases, reach a point where earlier treatment would have produced a significantly better outcome.

This is not an unfamiliar story to anyone in Ireland. But the scale of the problem, tracked in detail by the National Treatment Purchase Fund (NTPF), is often not fully appreciated even by those experiencing it. This article uses NTPF data, HSE performance reports and independent analyses to set out, as clearly as possible, what the waiting list crisis actually looks like, how many people are waiting, for how long, for what specialties, and in which parts of the country.

The Numbers: What the Data Shows

The National Treatment Purchase Fund publishes weekly waiting list data covering outpatient appointments, inpatient and day case procedures, and special categories including children waiting for community-based assessment. The NTPF figures are the most authoritative public measure of waiting lists in Ireland.

As of mid-2026, approximately 900,000 people are waiting for an outpatient appointment at an Irish public hospital. This figure — roughly one in five of the entire population, includes people at all stages of the waiting process, from those recently referred to those who have been waiting for three or more years. Of the total number waiting, approximately 70,000 have been waiting for more than 18 months, and around 20,000 have been waiting for more than three years.

A separate cohort, approximately 80,000 people, are waiting for an inpatient or day case procedure: surgery, a diagnostic procedure under anaesthetic, or a treatment requiring hospital admission. Within this group, approximately 12,000 have been waiting over 18 months. These are patients for whom a clinical decision has already been made that they require an intervention, the wait is purely a capacity issue.

Children’s waiting lists represent a particular crisis within the crisis. Waiting times for Child and Adolescent Mental Health Services (CAMHS) have been among the most reported aspects of the problem, as of early 2026, over 3,000 children were waiting for a first CAMHS appointment, with median waits running to twelve months or more in some Community Healthcare Organisations (CHOs). Waiting lists for paediatric specialist services, audiology, orthopaedics, ophthalmology are similarly extended.

Which Specialties Have the Longest Waits

Waiting times vary enormously by specialty. The longest waits in outpatient services are consistently found in dermatology, orthopaedics, ophthalmology, gastroenterology and rheumatology, specialties where demand is high, consultant capacity is constrained, and the conditions involved, while serious are not typically life-threatening in the short term, meaning patients are not routinely fast-tracked.

Dermatology waits in some hospitals exceed three years for a routine outpatient appointment. A patient referred by their GP for investigation of a suspicious skin lesion which may or may not be malignant, faces a wait that, if the lesion is malignant, could allow it to progress significantly before specialist assessment. The NTPF data does not capture clinical outcomes of waiting, but the clinical risk of extended dermatology waits is well-documented in international literature.

Orthopaedic waits are similarly extended, particularly for hip and knee replacement procedures. A patient over 65 waiting two or more years for a joint replacement is not merely experiencing inconvenience: they are living with pain and reduced mobility that affects their quality of life, their capacity for physical activity and through deconditioning their broader health outcomes. The economic cost of this wait in lost productivity and increased social care needs is real but rarely measured.

Cancer pathways are explicitly prioritised and are not comparable to routine outpatient waits, patients with suspected cancer are supposed to be seen within specific timeframes under rapid access clinic protocols. In practice, these protocols are met with varying consistency across hospital groups and cancer types, and the NTPF data shows that even within the cancer pathway, breaches occur.

Geographic Variation: Where You Live Determines How Long You Wait

One of the most striking features of Irish waiting list data is its geographic variation. Wait times for the same specialty can differ by a factor of three or four between hospitals in different parts of the country. The NTPF’s hospital-level data reveals that patients in some hospital catchment areas wait significantly longer than those in others, not because their clinical need is different but because the consultant capacity and throughput at their local hospital is lower.

University Hospital Kerry, Letterkenny University Hospital, and Portiuncula University Hospital in Ballinasloe have consistently appeared in the data with longer waits in multiple specialties than their counterparts in the larger Dublin and Cork hospitals. This reflects both the absolute size of the consultant workforce in smaller hospitals and the difficulty of recruiting specialists to more remote locations.

The effect is a two-tier system within the public system itself: if you live in Dublin and are referred to a major teaching hospital, you will in most specialties wait less long than a patient in rural Connacht or along the western seaboard. This is not a product of policy intent, no government has designed it this way but it is a consistent feature of the data that receives insufficient political attention.

What Has Been Done and Why It Has Not Been Enough

The primary State-level response to waiting lists has been the NTPF’s treatment purchase function: paying for patients who have waited beyond defined thresholds to be treated in private hospitals or abroad. The NTPF spent approximately €200 million in 2024 purchasing treatment for public patients, providing relief for a significant number of individuals but doing nothing to address the underlying capacity deficit in the public system.

The Sláintecare reform programme, a cross-party plan published in 2017 and adopted by successive governments as the framework for health reform sets out a ten-year trajectory toward universal healthcare with shorter waiting times, greater primary care capacity, and reduced reliance on hospital-based services. Implementation has been partial and uneven. The removal of inpatient charges, the expansion of GP visit card eligibility, and investment in community-based care teams are genuine Sláintecare deliverables. But the fundamental capacity issues, the number of hospital beds, the number of consultants, the number of community-based specialists, have not been resolved within the Sláintecare timeline.

Consultant numbers have increased, but the healthcare workforce internationally is in shortage, and Ireland competes with the UK, Australia, Canada and the US for trained specialists. Pay and conditions for public hospital consultants improved following lengthy negotiations, but the gap between public and private sector earnings remains a factor in how consultants allocate their working time.

What Patients Can Do

Patients who have been waiting beyond the NTPF’s published thresholds, 18 months for outpatient, 12 months for inpatient in most cases are eligible to be referred to the NTPF for treatment in an approved private facility at no additional cost to the patient. Patients can check their eligibility and request a referral through their GP or directly through the NTPF patient portal. This does not reduce the overall waiting list but does provide a practical route for individual patients.

Patients who believe their condition has deteriorated significantly since referral, or who have been waiting an exceptionally long time, should return to their GP and ask for the referral to be reviewed and marked urgent if clinically appropriate. Patients who are experiencing symptoms that suggest the condition is worsening should not simply wait for an appointment that may be months away. Patient Advocacy Services Ireland provides free advocacy support to patients navigating the public health system.

The waiting list crisis is not a problem that any individual action by any individual patient can resolve. It is a structural capacity problem that requires sustained investment in training, infrastructure and workforce planning over a decade or more. What individual patients can do is ensure they are using the tools available to them, NTPF purchase referrals, GP escalation, and advocacy services while the structural changes that are necessary slowly materialise.